1. Introduction {#sec1}
===============

Autologous fat transplantation, also known as fat grafting or lipofilling, is an increasingly popular technique used in reconstructive surgery of the breast. Autologous fat grafting (AFG) was first used for filling defects and remodelling body contours over a century ago; however, its current usage dates back to 1987, when Bircoll [@bib1] described a method that coupled liposuction with autologous transplantation of the harvested fat in the breast. The major advantage cited for this new technique was the presence of virtually limitless donor tissue that was soft and malleable [@bib1]. AFG can be used for simple, aesthetic augmentation of the breast, correction of breast asymmetry, correction of breast deformities, as an adjunct or primary tool in breast reconstruction, and for soft-tissue coverage of breast implants [@bib2]. An increasing number of authors proposed that lipofilling could improve the outcomes of total or partial reconstruction in breast cancer patients [@bib2], [@bib3], [@bib4]. Although several teams have used repeated lipofilling sessions for total breast reconstruction, most authors consider that the lipofilling technique is indicated for the local improvement of small defects or asymmetry only [@bib4], [@bib5], [@bib6]. Fat grafts are preferred over other graft types for the correction of volume and contour defects because fat is autologous, abundant, and easily harvested. Adipose tissue transfer in the form of fat grafting is now commonly used, and many variations on fat harvesting, preparation, and reinjection have been reported [@bib7]. The filler function, however, is not the only important aspect of AFG, and numerous studies have reported the regenerative effects of autologous fat grafts [@bib8], [@bib9], [@bib10]. These remarkable effects are particularly observed in irradiated tissue, and are most likely attributable to the high content of mesenchymal stem cells in fat grafts [@bib10], [@bib11], the quantity of which varies depending on the cell-isolation procedure used. However, initial attempts at AFG were often accompanied by a high rate of graft resorption and complications such as fat necrosis. Because the latter is associated with the formation of microcalcifications in the long-term, it caused concerns about possible interference with the prompt detection of breast cancer through mammography [@bib12]. This led to its disapproval by the American Society of Plastic and Reconstructive Surgeons (ASPRS) in 1987. The ASPRS made the following statement in regard to AFG: "The committee is unanimous in deploring the use of autologous fat injection in breast augmentation. Much of the injected fat will not survive, and the known physiological response to necrosis of this tissue is scarring and calcification. As a result, detection of early breast carcinoma through xerography and mammography will become difficult and the presence of disease may go undiscovered." [@bib2], [@bib13]. Nearly a decade later, Coleman introduced a new, refined technique of fat aspiration, purification, and injection that greatly improved graft survival and reduced the rate of complications [@bib14]. His technique consisted of three steps: manual lipoaspiration under low pressure, centrifugation for 3 min at 3000 rpm, and reinjection in 3D [@bib7]. Coleman technique was superior to conventional liposuction for harvesting and processing fat grafts because the Coleman fat grafts have a greater number of viable adipocytes and sustain more optimal cellular function than fat grafts harvested with conventional liposuction performed by an experienced surgeon [@bib7]. Approximately the same time, a growing body of literature emerged suggesting that other procedures performed on the breast, such as reduction mammoplasties, also lead to scarring that is visible during breast screening and is far in excess of what would be expected after lipofilling [@bib15], [@bib16], [@bib17]. Subsequent studies showed that these artefacts did not appreciably affect screening [@bib17], [@bib18]. In addition, several case reports and case series published over the years have not provided any definitive evidence to support these and other concerns about AFG. Finally, the lipofilling procedure has been greatly refined since its initial description, resulting in increased confidence in its use, including for breast reconstruction and remodelling [@bib17], [@bib19]. The recommendation against the procedure by the ASPRS, now known as the American Society of Plastic Surgeons, was reversed in 2009 [@bib17], [@bib20].

2. Application {#sec2}
==============

Acquired contour deformities of the reconstructed breast are relatively common and independent of the technique used, presenting a frequent therapeutic challenge to reconstructive surgeons [@bib21]. Primary breast reconstruction usually meets the goal of establishing a natural-appearing breast shape [@bib21]. However, in the immediate or late postoperative period, secondary contour defects of the reconstructed breast can develop [@bib21], [@bib22]. There are important landmarks in the female breast, and the creation of a well-defined inframammary fold during breast reconstruction is a fundamental element in obtaining a good aesthetic result [@bib23]. Autologous fat transplantation represents a simple solution to restore the profile of the breast after reconstruction. In fact, in breast cancer surgery, lipofilling is usually used for the correction of defects and asymmetry following tumour excision (or breast conservative surgery), with/without radiotherapy [@bib24]. Adequate tissue expansion allows the use of autologous flaps or the insertion of definitive prosthetic implants for breast reconstruction. Tissue expansion can be carried out with the aid of a computer program to help the surgeon select the appropriate tissue expander during the planning stage of breast reconstruction [@bib25], [@bib26]. However, lipofilling can be used to improve soft-tissue coverage following prosthesis or tissue expander implantation and the volume replacement of implants in unsatisfactory oncoplastic breast reconstruction outcomes. Other applications of AFG are volume augmentation and refinement after autologous flap or whole breast reconstruction with serial fat grafting or scar correction [@bib24].

3. Oncological safety {#sec3}
=====================

Autologous fat transplantation, as reported in the literature, can lead to fat necrosis and calcification but not significantly more frequently than after reduction mammoplasty [@bib27]. There is no scientific evidence that fat grafting interferes with breast cancer detection [@bib27], [@bib28], [@bib29]. The question of de novo cancer induction or accelerating growth of a pre-existing cancer by fat grafting has not been answered to date [@bib19]. Thus far, no guarantee of cancer safety in fat grafting can be given to patients, although there is no scientific evidence of increased breast cancer occurrence or recurrence after fat grafting at this time [@bib19].

4. Efficacy of lipofilling {#sec4}
==========================

Fat is a filler with ideal properties; it naturally integrates into tissues, is autologous, and is 100% biocompatible. However, this is not the only function of lipofilling. Fat is an active and dynamic tissue composed of several different cell types, including adipocytes, fibroblasts, smooth muscle cells, endothelial cells, and adipogenic progenitor cells called pre-adipocytes [@bib30], [@bib31], [@bib32]. Stem cells isolated from lipoaspirates have demonstrated a broad in vitro adipogenic, chondrogenic, osteogenic, and myogenic lineage commitment [@bib33], [@bib34] as well as differentiation into pancreatic cells, hepatocytes, and neurogenic cells [@bib35], [@bib36], [@bib37]. Cytometric analysis of adipose-derived stem cells (ASCs) has shown that these cells do not express CD31 and CD45, but do express CD34, CD73, CD105, and the mesenchymal stem cell marker CD90 [@bib38], [@bib39]. ASCs have a differentiation potential similar to that of other mesenchymal stem cells as well as a higher yield upon isolation and a greater proliferative rate in culture than bone marrow--derived stem cells [@bib40], [@bib41], [@bib42]. Owing to these potentials and because they can be easily harvested in great amounts with minimal donor-site morbidity, ASCs are particularly promising for regenerative therapies [@bib40], [@bib43]. ASCs are present in the so-called stromal vascular fraction (SVF) of adipose tissue [@bib44], together with a heterogeneous population of many other cell types, including pre-adipocytes, endothelial cells, pericytes, hematopoietic-lineage cells, and fibroblasts. The regenerative features of the SVF include its paracrine effects: SVF cells secrete vascular endothelial growth factor, hepatocyte growth factor, and transforming growth factor-β under different stimuli (e.g., hypoxia, growth factors) [@bib45], [@bib46] and strongly influence the differentiation of niche stem cells, promoting angiogenesis and wound healing, and potentially aiding new tissue growth and development [@bib43]. Mature adipocytes react in a variety of ways in response to the pre-adipocyte environment [@bib47]. In ischaemic conditions, these cells either die, survive, or undergo dedifferentiation; the dedifferentiated cells can re-accumulate fat and differentiate into adipocytes when an adequate vascular supply is re-established [@bib47], [@bib48], [@bib49] Adipocytes are sensitive to their environment, and have short lifespans once removed from the body; they do not react well to excessive handling, refrigeration, or major trauma during tissue collection or processing [@bib47], [@bib50]. Initially, the graft survives via the direct diffusion of nutrients from plasma; therefore, smaller grafts, with higher surface area--to--volume ratios have an advantage over larger grafts, as a greater proportion of the graft is in contact with the graft bed [@bib47], [@bib51], [@bib52]. This facilitates revascularisation [@bib47], [@bib53], which occurs as early as 48 h post-transplantation [@bib47], [@bib54]. Large grafts exhibit higher rates of liquefaction, necrosis, and cyst formation, while very small grafts tend to be reabsorbed [@bib47], [@bib55]. To ensure maximal take, many surgeons perform repeated transfers [@bib47], [@bib56], [@bib57], [@bib58]. In breast reconstruction surgery, fat transplantation can be used not only to fill atrophic scars but also to reduce scar contracture as a regenerative alternative to other surgical techniques [@bib59]. From a histological point of view, autologous fat grafts containing ASCs show the ability to regenerate the dermis and subcutaneous tissue and improve the dermal and new collagen deposition, and local neoangiogenesis [@bib60], [@bib61], [@bib62]. Mojallal et al. [@bib63] showed that fat tissue grafting stimulates the neosynthesis of collagen fibres at the recipient site and makes the dermis thicker, thereby improving skin quality. Rigotti et al. [@bib8] reported that the transplantation of lipoaspirates containing adult ASCs is a highly effective therapeutic approach for the treatment of degenerative, chronic lesions induced as late effects of oncologic radiation treatments. In fact, ultrastructural analysis of the radio-damaged tissue revealed a significant reduction of the capillary bed [@bib8]. Owing to the angiogenic factors released from ASCs, lipofilling interrupted a vicious circle of vascular lesion, ischaemia, hyperpermeability, and fibrosis leading to increased ischaemia, and favoured the growth of a microvascular bed with the correct ratio of adipocytes to capillaries [@bib8].

5. Surgical technique {#sec5}
=====================

Several techniques for fat harvesting and lipofilling are currently being employed. In all of these techniques, autologous fat is harvested, processed, and grafted [@bib17]. Before surgery, the various adipose areas of the body are examined to identify natural fat deposits. The most common donor site is abdominal fat because it is one of the largest fat deposits. The second most common sites are the greater trochanteric region (saddle bags) and the inside of the thighs and knees [@bib24]. Several techniques have been proposed for fat harvesting, and there is an ongoing debate in the literature as to which method produces more viable and functional adipocytes. The most frequently used methods for fat harvesting are vacuum aspiration or syringe aspiration with or without the infiltration of tumescent fluid. The "wet" technique involves the injection of a tumescent fluid consisting of NaCl, epinephrine, and a local anaesthetic drug, e.g., Klein solution [@bib64]. The shear stress exerted on harvested fat has been determined to decrease adipocyte viability, and a low shear stress improves graft survival [@bib17]. An alternative "dry" method of graft harvesting without the tumescent fluid can also be used. Cell viability in the samples harvested in this manner has been found to be similar to that observed in samples harvested by the "wet" method [@bib17], [@bib65]. However, the "dry" technique may lead to a greater requirement for analgesics [@bib17], [@bib64]. It is widely accepted that less-traumatic methods of fat harvesting result in increased adipocyte viability and graft survival [@bib66], [@bib67]. Coleman et al. [@bib9] described a technique for fat harvesting that minimized trauma to the adipocytes. With a 3-mm, blunt-edged, 2-hole cannula connected to a 10-mL syringe, fat is suctioned manually by withdrawing the plunger. Erdim et al. [@bib68] reported higher graft viability with lipoaspirates that were obtained using a 6-mm cannula rather than a 4-mm or 2-mm cannula. . Keck et al. have shown that suction-assisted lipoaspiration (SAL) with 0.5-bar negative pressure leads to cell yield and viability comparable to manual lipoaspiration [@bib69]. Recently new methods of lipoaspiration have been developed such as suction- or power-assisted, laser-assisted, and ultrasound-assisted liposuction. These techniques were developed with the goal of achieving rapid tissue harvest, promoting skin tightening, and minimizing harvest-site morbidity [@bib70]. Ultrasound-assisted liposuction (UAL), is gaining popularity for its ability to improve the process of lipoaspiration, by decreasing blood loss and tissue trauma [@bib71]. During UAL, a specialized probe or cannula is used that transmits ultrasound vibrations into the fat tissue [@bib70]. The vibrations lead to emulsification of the fat, making it easier to remove [@bib72]. Dusher et al. [@bib73] evaluated the regenerative abilities of ASCs harvested via a third-generation ultrasound-assisted liposuction (UAL) device versus ASCs obtained via standard suction-assisted lipoaspiration (SAL). They reported that ASCs obtained via UAL were of equal quality when directly compared with SAL [@bib73]. Alternatively, laserassisted liposuction (LAL), which uses thermolysis to selectively lyse adipocytes, has been shown to decrease ASCs yield and viability as compared with SAL [@bib74].

The most frequently used methods for fat processing are centrifugation, washing, and decantation. The widely used protocol to separate purified fat from call debris is the centrifugation, as described by Coleman [@bib75]. Once the fat is harvested, the fat syringes are centrifuged at 3000 rpm for 3 min. After centrifugation, the lipoaspirate is separated into four layers: (a) the oily fraction, which leaks out of disrupted adipocytes; (b) the watery fraction, which consists of blood, lidocaine, and saline injected before the liposuction; (c) a cell pellet on the bottom; and (d) purified fat between the oily and watery fractions [@bib24]. Subsequently, under local anaesthesia, the skin of the breast is punctured with an 18-gauge cannula that is used to release dermatofascial adhesions and scar tissue. The same cannula is then used to inject the fat graft in the subcutaneous and subglandular plane of the breast ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}a,b).

The washing technique of fat processing is performed as follows: the harvested fat is washed with normal saline [@bib76] or 5% glucose solution [@bib77] to remove blood, the oily fraction, and cellular debris from the aspirated fat [@bib24]. The least popular technique of fat processing is decantation, which uses gravity to precipitate the cellular component from the oily and watery components [@bib24].

6. Complications {#sec6}
================

Fat tissue that is not perfused can die and result in necrotic cysts and even calcifications; however, these complications can occur after any type of breast surgery [@bib2]. It was thought that fat grafting to the breast could potentially interfere with breast cancer detection; however, no conclusive evidence of such interference has been found [@bib78]. Two cases of breast cancer after fat grafting to the breast were reported, but there was no delay in detection or treatment in these cases [@bib78]. Radiological studies suggest that imaging technologies (ultrasound, mammography, and magnetic resonance imaging) can identify the grafted fat tissue, microcalcifications, and suspicious lesions; biopsies may be performed, if needed, for additional clarification [@bib78]. The use of minuscule incisions and the blunt nature of the technique minimize the possibility of damaging the underlying structures such as nerves, ducts, and blood vessels [@bib2]. Largo et al. [@bib19] reported that among 1453 patients who underwent lipofilling of the breast, the most common complications were palpable nodules not requiring any surgical intervention (7%), unsatisfactory results in terms of volume, shape, and/or symmetry (3%), and infections (0.7%). Dysaesthesia, lymphadenopathy, pain, or haematoma seem to be less of a concern. No decrease in nipple sensitivity or lactation disorder due to fat grafting to the breast has been reported [@bib19]. Death resulting from fat grafting has not been described [@bib19]. Furthermore, donor-site complications appear to be minimal and related to the liposuction technique [@bib24]. Possible donor-site complications include bruising, swelling, haematoma formation, paraesthesia or donor-site pain, infection, hypertrophic scarring, contour irregularities, and damage to underlying structures such as intraperitoneal or intramuscular penetration of the cannula [@bib24]. Early experience noted that graft re-absorption was the main drawback of AFG, with 50%--90% graft-loss rates being reported [@bib47], [@bib79], [@bib80], [@bib81]. Large grafts exhibit higher rates of liquefaction, necrosis, and cyst formation, while very small grafts tend to be reabsorbed [@bib47], [@bib55]. To ensure maximal take, many surgeons perform repeated transfers [@bib47], [@bib56], [@bib57], [@bib58]. Groen et al. [@bib82] in a review of 33 studies reported 461 complications in a total of 5502 patients. The reported total complication rate was 8.4% (95% CI 7.6--9.1) including nodules/masses 11.5%, cyst formation 6.9%, haematoma 6.3%, calcifications 5.2%, straie of breast 4.4%, fat/liponecrosis 4%, granulomas 3.6%, infections/cellulitis 0.8%, seroma 0.8%, donor site infections 0.7%, abces 0.6%, pneumothorax 0.2%, delayed wound healing 0.1%. Agha et al. [@bib83] in a review of 24 studies reported 207 complications, 7,3% of 2832 treated breasts. Fat necrosis accounted for 62% of all complications and occurred in 17 of the 24 studies.

7. Discussion {#sec7}
=============

Plastic surgeons and patients may have drastically different ideas of what constitutes an attractive, natural, and ideal breast shape [@bib84], [@bib85]. As with any surgical procedure, the technique used, the execution of the technique, and the experience of the surgeon affect the outcome. After mastectomy and breast reconstruction both with autogenous flaps and with implants, patients may notice subtle deformities and deficiencies, and consider their reconstructions incomplete [@bib2], [@bib86]. Grafted fat can provide missing coverage and may relax the breast capsule [@bib2], [@bib86]. Fat can be grafted in large or small volumes to correct otherwise difficult problems such as axillary deficiencies, poor breast shape, visible implant edges, capsular contracture, and even radiation damage [@bib2], [@bib86]. Often patients find the improvement after this procedure insufficient, and the procedure should be repeated to obtain a fully satisfying result. Beck et al. [@bib87] reported an objective, computed tomography analysis that showed low fat-resorption rates during the first 3 months (0%--9.54%). The average fat resorption rate increased to 51.72% between the third and ninth months. The rate of fat resorption remained stable after the ninth month, and even seemed to be lower (44.02%) after 3 years. Every step in fat transplantation, i.e., harvesting, processing, and transplantation, is important, but viability of the harvested fat cells is crucial [@bib88]. The chances of survival are higher the less the fat graft is manipulated and the more quickly it is re-injected [@bib89]. Transplanted fat is vulnerable to pressure. Constricted skin with a very thin or scarred subcutaneous fat layer cannot sustain as large an amount of fat as healthy tissue, preferably with lax skin and a thick subcutaneous fat layer [@bib88]. In fact, the vitality of ASCs has proven to be crucial for stimulating tissue regeneration through the chemotactic, paracrine, and immunomodulatory activities of the cells and in situ differentiation [@bib38], [@bib39].

8. Conclusion {#sec8}
=============

In breast cancer surgery to correct irregularity and deformities, autologous fat transplantation is an acceptable procedure that does not compromise oncological outcomes and minimizes discomfort to the patients. The role of lipofilling for breast reconstruction could be more significant with the application of the findings of experimental research on tissue engineering and ASCs. Thus far, no guarantee of cancer safety in fat grafting can be given to patients, although there is no scientific evidence of increased breast cancer occurrence or recurrence after fat grafting at this time.
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![a -- 40 year old patient subjected to mastectomy and recostruction with implants. Before treatment with lipofilling. b -- 40 year old patient subjected to outer upper left quadrantectomy. After treatment with lipofilling at the level of the upper outer scar of left breast.](gr1){#fig1}

![a -- 38 year old patient subjected to mastectomy and recostruction with implants. Before treatment with lipofilling. b -- 38 year old patient subjected to mastectomy and recostruction with implants. After treatment with lipofilling at the level of the scar of right breast.](gr2){#fig2}

![a -- 35 year old patient subjected to mastectomy and recostruction with implants. Before treatment with lipofilling. b -- 35 year old patient subjected to mastectomy and recostruction with implants. After treatment with lipofilling at the level of the scar of left breast.](gr3){#fig3}
